.
The goal of regenerative periodontal therapy is the restitution of a periodontal attachment apparatus at a root surface that was previously occupied by a microbial plaque. It was documented that this objective can be met by the use of various graft materials, barrier membranes, root surface conditioning or a combination of such techniques (for review, see Garrett (1996) ). The use of an enamel matrix derivate (Emdogain A , Biora, Sweden) was recently suggested as an alternative to bone grafts and barrier membranes in the treatment of intrabony periodontal defects (Hammarströ m 1997 . Enamel matrix proteins are important during the development of the root for the formation of acellular cementum, periodontal ligament and alveolar bone (Hammarströ m 1997). The safety of Emdogain A was documented by Zetterströ m et al. (1997) .
Findings from a multicenter study by Heijl et al. (1997) 
indicated that topical application of Emdogain
A on detached root surfaces at intrabony defects during periodontal flap surgery will ''promote and increase gain of radiographic bone and clinical attachment compared to control surgery (placebo application) in the same patient''. Mellonig (1999) reported data from a Case Report with a 1-year follow-up documentation. A maxillary premolar with an interproximal deep pocket and advanced attachment loss was treated with a flap technique and Emdogain A placement. The author reported that this regenerative treatment resulted in a 5-mm reduction in probing depth and a 4-mm gain in clinical attachment. Mellonig (1999) , in addition, described the histological outcome of Emdogain A treatment of a mandibular canine. 6 months after surgery, a clinical examination disclosed 5 mm reduction in probing depth and 4 mm probing attachment gain. The canine and adjacent bone were removed, decalcified and sectioned. The histological examination revealed the presence on the treated root surface of a thin, newly formed cementum, periodontal ligament and bone.
The aim of the present Case Report Series was to evaluate the extent and predictability of probing attachment level gains following the use of enamel matrix proteins in intrabony defects.
Material and Methods

Sample
The study population comprised 108 consecutively-treated subjects (56 female and 52 male) who were referred for treatment of advanced periodontal disease. The mean age of the patients was 55.8 years (SD 12.7). 31 of the 108 patients were smokers.
A screening examination revealed that each subject exhibited at least 1 deep intrabony defect that could be identified as an experimental site based on the following inclusion criteria: (i) probing pocket depth (PPD) у5 mm, (ii) probing attachment loss (PAL) у6 mm, (iii) radiographic evidence of an interproximal bone defect with a у3 mm intrabony component.
The patients first received non-surgical periodontal therapy. This included oral hygiene instruction, plaque control monitoring and scaling and root planing. The subgingival instrumentation, which required several sessions, was performed by a periodontist or a specially-trained dental hygienist and included all parts of the dentition. The subgingival debridement was consistently performed under local anaesthesia.
Baseline examination
At least 6 months after the completion of this treatment, a baseline examination was performed to characterise the experimental sites. This examination included dichotomous local (i) plaque score and (ii) bleeding on probing score. In addition, probing pocket depth (PPD) from the gingival margin, probing attachment level (PAL) from the cemento-enamel junction (CEJ), and marginal soft tissue recession (REC) from the CEJ were recorded with a periodontal probe to the nearest mm at both the buccal and lingual aspects of the interdental site.
Regenerative periodontal therapy
Immediately before the surgical treatment, the patients rinsed the mouth with a 0.2% chlorhexidine solution for 90 s. The area subjected to surgery was anaesthetised with Xylocain A adrenaline 2% (Astra AB, Sweden). Following pocket and releasing incisions, buccal and lingual full-thickness flaps were elevated and the epithelium was removed from the inside of the flaps. Granulation tissue residing in the defect area was carefully excised and the root surface scaled and planed. No bone recontouring was performed.
Following the debridement of the site, assessments were carried out with respect to:
(i) the position of the bone crest in relation to CEJ (distance CEJ-BC);
(ii) the position of the bottom of the bony defect in relation to CEJ (distance CEJ-BoBD);
(iii) the depth of the intrabony component of the periodontal defect (IN-TRA; distance BC-BoBD). The bone defect was also classified according to the number of lining bone walls (1-, 2-, 3-wall defect or combinations).
A gel containing 24% EDTA was then applied on the exposed portion of the root in order to remove the smear layer. The gel was kept in place for 2 min, after which the surgical area was rinsed with saline. Subsequently, the EMDOGAIN A (Biora AB, Malmö , Sweden) preparation (enamel matrix proteins in a propylene glycol alginate vehicle) was applied to the root surface and adjacent defect space. The flaps were replaced and closed with sutures. After a healing period of 2 weeks, the sutures were removed.
72 of the 108 patients received systemic antibiotic therapy (Vibramycin, Amoxicillin or Metronidazole) for 10 days in conjunction with the surgical treatment. The subsequent 36 patients were not given adjunctive antibiotic treatment. All patients were instructed to rinse, 2¿ daily with a 0.1 or 0.2% solution of chlorhexidine digluconate. Mechanical cleaning of the surgical site was not recommended during the first 6 post-operative weeks. Recalls for supportive care including professional tooth cleaning were scheduled 1¿ every 2-4 months. The experimental sites were re-examined 12 months after regenerative therapy.
Radiographic examination
Periapical radiographs were obtained by the use of a long-cone parallel technique at baseline and at the 12-month re-examination. In the radiographs, the following distances were measured to the closest 0.5 mm using a transparent ruler and a magnifying lens (¿2.5).
(i) Defect depth, i.e., the vertical distance between the bone crest and the most coronal level along the root surface at which the periodontal ligament space was considered as having a normal width
(ii) Defect width, i.e., the perpendicular distance between the root surface and the lateral wall of the bone defect at the level of the bone crest.
Data analysis
For the data analysis with respect to clinical probing assessments, the buccal or lingual site data that showed the greatest PAL value at baseline were selected. For each variable and examination interval, mean values and standard deviations were calculated. The amount of radiographic bone fill was determined as a % of the original defect using the following formula:
Alterations in the various variables over time were statistically analysed using the Student t-test for paired comparison. An a error of 0.05 was accepted for statistical significance. A stepwise regression model was employed for the analysis of factors influencing the outcome variable PAL change. The model included both quantitative variables and qualitative (dummy) variables. The F-value for a factor to be entered into the model was set at 4.
Results
A total of 145 interproximal intrabony defects in the 108 patients included in the study fulfilled the inclusion criteria. 76 patients presented with 1 qualifying site, 28 patients with 2 sites, 3 patients with 3 sites and 1 patient with 4 sites.
Since an analysis performed to evaluate the interaction between subject and PAL change following treatment revealed no statistically significant interaction, the data analysis in this report was based on the site level. 
Baseline defect characteristics
Out of the 145 sites treated, 104 were located in the maxilla and 41 in the mandible; 74 of the sites exposed to regenerative therapy were located adjacent to a mesial, and 71 adjacent to a distal tooth surface. Out of the 104 maxillary defects, 57 were present in the Fig. 1 . Radiographic illustrations of the outcome of the Emdogain A treatment. Top: a 1-2 wall defect at the mesial aspect of tooth 23 before treatment (A) and at the 1-year follow-up examination (B). Middle: a 1-2 wall defect at the mesial aspect of tooth 46 before treatment (C) and at the 1-year follow-up examination (D). Bottom: a 2-wall defect at the distal aspect of tooth 45 before treatment (E) and at the 1-year follow-up examination (F).
incisor/canine segment of the dentition, 42 in the premolar and 5 in the molar regions (Table 1 ). The corresponding distribution of the mandibular defects was 18 (incisor/canine), 15 (premolar), and 8 (molar).
The frequency distribution of 1 wall, 1π2 wall, 2-wall, 2π3 wall, and true 3-wall defects is presented in Table 2 . 94% of the defects were of 1-and 2-wall character. About 80% of the intrabony defects were у4 mm deep.
Treatment outcome
The overall therapeutic response is presented in Table 3 . At the 1-year posttreatment examination, there was a mean probing pocket depth reduction of 5.2 mm (p∞0.001) and a corresponding mean probing attachment gain of 4.6 mm (p∞0.001). The additional softtissue recession amounted on the average to 0.6 mm (p∞0.01). The radiographic assessments revealed that the bone defect had been reduced in depth by on the average 2.9 mm (p∞0.001) and in width by 1.3 mm (p∞0.001). Hence, the reduction in defect size corresponded to an average bone fill of 69% of the original defect. In 43% of the defects, the bone fill amounted to у80%. Fig. 1 presents some illustrations of radiographic bone alterations observed following the Emdogain A therapy. To characterise the variation in the probing attachment gain between baseline and 12 months, the results were stratified into 4 different gain classes according to a system originally described by Cortellini et al. (1993) . Thus, Table  4 reports some Baseline defect characteristics at sites that exhibited a probing attachment gain of (i) ∞2 mm, (ii) у2 mm -∞4 mm, (iii) у4 mm -∞6 mm and (iv) у6 mm. One site lost attachment as a result of treatment and was omitted in this description. From the data presented, it is observed that 6% of sites gained ∞2 mm of probing attachment, while the vast majority of sites (68%) gained у4 mm of clinical attachment. The probing attachment gain increased with increasing baseline probing pocket depth, probing attachment loss, and amount of bone loss.
Defects showing у6 mm gain in probing attachment had on average a PPD of 9.4 mm, a PAL of 11.2 mm, and a bone loss of 12.1 mm, with an intrabony component of 7.2 mm. Statistically-significant differences were observed among probing attachment level gain classes (regression model) in terms of baseline PAL and CEJ-BoBD (p∞0.001). The stepwise regression model formulated for the analysis of factors influencing the treatment outcome (PALchange) revealed that, at the order of entrance into the model, (i) amount of soft tissue recession during healing (FΩ 251.7), (ii) initial PPD (FΩ235.3), (iii) BoP at the follow-up examination (FΩ 7.4), and (iv) smoking (FΩ5.7) significantly contributed to the observed variability in the outcome variable. The adjusted R 2 for the regression model was 0.76. It should be realised that characteristics such as (i) adjunctive antibiotic therapy, (ii) type of bone defect, (iii) jaw (maxilla or mandible), and (iv) depth of the intrabony defect did not reach the defined F-value for entrance into the model.
Discussion
The present study demonstrated that regenerative therapy including the application on the instrumented root surface of enamel matrix proteins (Emdogain A ) at sites with angular bone defects resulted in a mean probing attachment gain of 4.6 mm and a probing pocket depth reduction of 5.2 mm. 87% of all sites treated exhibited a probing attachment gain of ±2 mm.
The sample included in the study comprised 108 consecutive periodontal patients with a total of 145 angular bone defects. The treatment was provided at 1 centre and by 1 clinician. No control procedure was included in the investigation. Hence, the study design does not permit an immediate comparison with other regenerative procedures.
The present findings, nevertheless, are in general agreement with data from controlled clinical studies on the use of enamel matrix proteins previously reported. Thus, Heijl et al. (1997) , in a prospective multicenter trial, reported an average probing attachment gain of 2.1 mm and 2.3 mm at 8 and 16 months after Emdogain A treatment, while control therapies yielded corresponding gains of 1.5 mm and 1.7 mm. Recently, Pontoriero et al. (1999) compared the outcome of various regenerative therapies including either the use of barrier membranes or topical application of Emdogain A . The experimental treat-ments were compared, in each patient, with a control procedure that involved open-flap curettage without adjunctive measures. The authors reported that sites which were exposed to enamel matrix protein application exhibitedafter 12 months -significantly greater probing pocket depth reduction (4.4 mm versus 3.5 mm) and probing attachment level gain (3.0 mm versus 1.8 mm) than control sites in the same patients.
The mean amount of probing attachment gain (4.6 mm) that was achieved in the current study is somewhat greater than that reported by Heijl et al. (1997) and Pontoriero et al. (1999) . This additional improvement of the clinical attachment level was not related to different baseline characteristics of the defects treated in the present and in the previous samples, but may be the result of a more stringent plaque control regimen used both before and after regenerative surgery in the present trial. First of all, all patients had been treated for advanced periodontal disease and were included in a carefully supervised supportive periodontal care program. Thus, their oral hygiene was already excellent at the start of the present trial and, hence, the number of micro-organisms present in the oral cavity must have been comparatively low (Bollen et al.1998) . Furthermore, during the first 6 postoperative weeks, the patients rinsed, 2¿ daily, with 0.1-0.2% chlorhexidine digluconate in an attempt to reduce further the number of oral bacteria. During this initial 6-week interval, no mechanical instrumentation of the surgical site was allowed and only subsequently was the self-performed toothbrushing and the interdental cleaning with mechanical aids recommended and professional cleaning reinstituted. There are reasons to suggest that the reduced bacterial load and the exclusive use of chemical plaque control measures may have established optimal conditions for healing at the treated sites (Cortellini et al. 1995; Tonetti et al. 1996) .
The regression analysis disclosed that soft tissue recession had a strong influence on the gain of probing attachment. For the entire sample, this recession amounted on the average to 0.6 mm. This amount of soft-tissue shrinkage is considerably lower than that reported in the study by Pontoriero et al. (1999) . 1 year after active therapy, they observed that the mean recession of the gingival margin was on the average 1.7 mm. It is suggested that a minimal amount of soft tissue recession may favour attachment gain.
The newly-formed attachment apparatus emanates from the granulation tissue formed between the flap and the root surface. It is likely that the evasion of mechanical plaque control measures at the surgical site during the first phase of healing may have prevented movements between this immature granulation tissue and the root surface, thus favouring wound stability. Such frequently-repeated soft tissue dislocations could have caused severance of the newly-formed attachment.
One important reason for the comparatively great probing attachment gain (compared to Heijl et al. (1997) and Pontoriero et al. (1999) ) obtained in the present sample, may also relate to the experience and technical skill of the clinician. The periodontist who performed all regenerative procedures in the current patient sample was, from 1989, part of the development of the clinical protocol for Emdogain A , and he was one of the surgeons who was involved in the multicenter study on the use of ''enamel matrix proteins in the treatment of intrabony periodontal defects'' by Heijl et al. (1997) . It is implied that the outcome of Emdogain A -treatment of intrabony defects is as operator-sensitive as GTR procedures (Tonetti et al. 1998) .
The overall probing pocket depth reduction (5.2 mm), probing attachment level gain (4.6 mm) and recession of the gingival margin (0.6 mm) that resulted following Emdogain A therapy in the present study, is similar to corresponding outcome variables following GTR (for review, see Laurell et al. (1998) Schlußfolgerung: Die Gesamtreduktion der Sondierungstiefe, der Attachmentgewinn sowie die Geweberezession, die sich nach Behandlung mit Emdogain A ergibt, ist vergleichbar mit den entsprechenden Ergebnisvariablen nach der GTR-Behandlung.
Ré sumé
Remaniements du tissu gingival après traitement par Emdogain
A de sites parodontaux avec défauts osseux angulaires. Série de compte rendus de cas Le but de la présente étude était de détermi-ner la prévisibilité du gain d'attache et de la réduction des profondeurs de poche, mesurés par sondage, après traitement par Emdogain A dans des sites présentant des défauts angulaires profonds.
Matériel et Méthodes:
108 patients parodontaux traités consécutivement (âge moyen 55.8 ans) ont participé à cette étude. Chacun des sujets présentait au moins un défaut interproximal infra-osseux profond, que l'on pouvait identifier comme site expérimental sur la base des critères d'inclusion suivants: (i) profondeur de poche au sondage у5 mm, (ii) perte d'attache au sondage у6 mm, (iii) défaut osseux interproximal visible sur radiographie avec un élément infra-osseux у3 mm. Au total, 145 défauts satisfaisaient à ces critères d'inclusion. Tous les sujets ont reçu un traitement parodontal non chirurgical, qui comportait l'instrumentation sous-gingivale au niveau de toutes les dents excepté au niveau du site expérimental. Au moins 6 mois après la fin de ce traitement, un examen initial (baseline) a été effectué pour définir les caractéristiques du site expérimental. Le traitement de reconstruction a ensuite été pratiqué. Des lambeaux parodontaux muco-pé-riostés ont été élevé, et la surface radiculaire a été détartrée et surfacée. Le contour osseux n'a pas été rectifié. Un gel contenant 24% d'EDTA a été applieué sur la racine dénudée et maintenu en place pendant 2 min. Une application de protéines de la matrice de l'émail a été faite sur la surface radiculaire et dans l'espace du défaut adjacent. Les lambeaux ont été repositionnés et suturés. Les sites expérimentaux ont été réexaminés 12 mois après la chirurgie de reconstruction.
Résultats: Le réexamen a montré qu'un traitement comportant l'application de protéines de la matrice de l'émail au niveau de sites parodontaux présentant des défauts angulaires produit un gain moyen du niveau de l'attache de 4.6 mm et une réduction de la profondeur de poche au sondage de 5.2 mm. Dans 87% de tous les sites traités on constatait au sondage un gain d'attache ±2 mm. Dans un des sites, le sondage révélait une perte d'attache. Les mesures radiographiques mettaient en éviden-ce que la profondeur du défaut osseux était en moyenne réduite de 2.9 mm. La réduction de la taille du défaut correspondait à un comblement osseux moyen de 69% du défaut initial. Dans 43% des défauts, le comblement osseux atteignait у80%.
Conclusion: Dans l'ensemble, la réduction de la profondeur de poche au sondage, le gain du niveau de l'attache au sondage et la récession des tissus mous qu'on obtient après le traitement par Emdogain A sont semblables aux variables correspondantes obtenues après RTG.
